Sphaerochaeta associata sp. nov., a spherical spirochaete isolated from cultures of Methanosarcina mazei JL01

International Journal of Systematic and Evolutionary Microbiology
Olga TroshinaViktoria Shcherbakova

Abstract

An anaerobic, saccharolytic bacterial strain designated GLS2T was isolated from aggregates of the psychrotolerant archaeon Methanosarcina mazei strain JL01 isolated from arctic permafrost. Bacterial cells were non-motile, spherical, ovoid and annular with diameter 0.2-4 μm. They were chemoorganoheterotrophs using a wide range of mono-, di- and trisaccharides as carbon and energy sources. The novel isolate required yeast extract and vitamins for growth. The bacteria exhibited resistance to a number of β-lactam antibiotics, rifampicin, streptomycin and vancomycin. Optimum growth was observed between 30 and 34 °C, at pH 6.8-7.5 and with 1-2 g NaCl l- 1. Isolate GLS2T was a strict anaerobe but it tolerated oxygen exposure. On the basis of 16S rRNA gene sequence similarity, strain GLS2T was shown to belong to the genus Sphaerochaeta within the family Spirochaetaceae. Its closest relatives were Sphaerochaeta globosa BuddyT (99.3 % 16S rRNA gene sequence similarity) and Sphaerochaeta pleomorpha GrapesT (95.4 % similarity). The G+C content of DNA was 47.2 mol%. The level of DNA-DNA hybridization between strains GLS2T and BuddyT was 34.7 ± 8.8 %. Major polar lipids were phosphoglycolipids, phospholipids and glycolipids; major fatty acid...Continue Reading

References

Mar 12, 1979·Human Genetics·M ThangaveluA J Therkelsen
Oct 15, 1992·FEMS Microbiology Letters·P D Franzmann, S J Dobson
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Oct 1, 1982·Applied and Environmental Microbiology·J D Buck
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Oct 1, 1986·Applied and Environmental Microbiology·D R Lovley, E J Phillips
Jan 5, 2006·Applied and Environmental Microbiology·Stefan DrögeHelmut König
Apr 13, 2007·FEMS Microbiology Ecology·Elizaveta RivkinaDavid Gilichinsky
Feb 13, 2009·Nature·M LeaverJ Errington
Feb 27, 2009·The ISME Journal·Delphine RivièreAbdelghani Sghir
Mar 15, 2011·International Journal of Systematic and Evolutionary Microbiology·Kirsti M RitalahtiFrank E Löffler
May 5, 2012·PloS One·Floyd E DewhirstZoe V Marshall-Jones
Nov 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Alison E MurrayPeter T Doran
Jun 20, 2013·Journal of Bioscience and Bioengineering·Zhiling LiArata Katayama
Oct 18, 2013·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
Sep 25, 2014·International Journal of Systematic and Evolutionary Microbiology·Masayuki MiyazakiHiroyuki Imachi

❮ Previous
Next ❯

Citations

Dec 1, 2017·The Journal of General and Applied Microbiology·Sidnei C SantosIrene Sánchez-Andrea
Sep 13, 2017·International Journal of Systematic and Evolutionary Microbiology·Y ShivaniCh V Ramana

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Archaeogenetics

Recent advances in genomic sequencing has led to the discovery of new strains of Archaea and shed light on their evolutionary history. Discover the latest research on Archaeogenetics here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

International Journal of Systematic and Evolutionary Microbiology
Bram VanparysPaul De Vos
International Journal of Systematic and Evolutionary Microbiology
Kirsti M RitalahtiFrank E Löffler
International Journal of Systematic and Evolutionary Microbiology
Bram VanparysPaul De Vos
© 2021 Meta ULC. All rights reserved